Heron Therapeutics Inc vs Simon Property Group Inc — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Simon Property Group Inc trades at $227 (market cap $74.00B). The key difference: Simon Property Group Inc is far larger — about 809.1× Heron Therapeutics Inc's market cap, and Simon Property Group Inc pays a 3.86% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | SPG | |
|---|---|---|
Market Cap | $91.46M | $74.00B |
Sector | Health | Real Estate |
52-Week High | $1.96 | $228.70 |
52-Week Low | $0.39 | $160.68 |
Enterprise Value | $189.36M | $102.48B |
Dividend Yield | — | 3.86% |
Trailing returns across standard periods
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →